SMTI: Falling Wedge detected on 12 Nov 2026

All prices, scores, and news on this page reflect data available before market open on .

Free example: 1 of 47 setups from the 12 Nov 2026 scan. Subscribers get the full list every trading day by 6 AM ET.

On 12 Nov 2026, our scan flagged SMTI as a falling wedge setup scoring 67 out of 98 (Moderate tier), with a 74% win probability based on our historical pattern database and a 0.70 to 1 risk to reward profile from the published levels. This is a swing trade setup: win probability reflects a multi-day swing hold, not an intraday move. At $31.61, the conservative target is $33.52 with a stop at $28.90.

67 of 98
Moderate
74%
High
0.70 : 1
$1.91 to target $2.71 to stop
Swing Trading Plan
Entry
$31.61
$33.52
$28.90
1-7 trading days
Exp. Reward
+$1.17
Exp. Risk
-$0.28

Expected figures are probability-weighted from our historical pattern database; Trade R:R is measured from the entry, target and stop levels.

Current Setup
SMTI is forming a falling wedge pattern with a bullish flag nested within it (formed Nov 3). Current price at $31.61 sits 96.95% from the 52-week low, sandwiched between support at $29.23 and resistance at $32.28. Structure score of 12.0 and breakout score of 13.0 indicate a moderately clean pattern, though volume at 41.6k shares (39% of 20-day average) shows below-average participation. The overall score of 67.0 and win probability of 73.7% suggest reasonable pattern reliability, but weak volume may require confirmation on approach to resistance.
Stock Context
SMTI faces merger uncertainty that appears to be pressuring recent price action. Shareholders overwhelmingly approved the MiMedx acquisition on September 30, 2026, but regulatory approval remains pending under Hart-Scott-Rodino review with an October 15, 2026 deadline that has since passed. This regulatory limbo likely explains why the stock has declined 10.05% over the past month and 11.01% from 52-week highs. Operationally, Q2 2026 results (reported August 11) showed revenue of $28.1M (+9% YoY) with 93% gross margin and soft tissue repair sales up 11%, demonstrating underlying surgical segment momentum. The merger-driven uncertainty has likely disconnected fundamentals from price, creating technical setup opportunity as investors await regulatory clarity.
What to Expect
A successful falling wedge breakout above $32.28 resistance would target $33.52 (conservative measured move), implying a 6% upside from current levels. The 73.7% win probability suggests historical success, but this breakout requires volume confirmation—current 0.39 volume ratio indicates institutions have not yet accumulated aggressively. Invalidation occurs on a breakdown through support at $29.23, representing a 7.5% downside. Given the Healthcare sector regime at +0.89 (bullish) contrasting a bearish market regime at -0.23, a breakout would suggest sector rotation outweighing macro headwinds.
Risk Factors
The pending MiMedx merger represents the primary tail risk—any HSR rejection or deal collapse would likely trigger sharp downside momentum as the merger premium would evaporate. RSI at 29.2 indicates oversold conditions from recent selling but also suggests limited additional downside cushion if merger news sours. Volume at 39% of average is concerning; thin participation increases gap risk and limits institutional conviction. Elevated volatility (20-day: 23.85%) paired with a micro-cap trading profile creates slippage risk on breakout execution. Bone fusion sales declined 8% in Q2, a weakness that may resurface post-merger integration. The stock remains 11% below 52-week highs despite solid fundamentals—this suggests merger deal risk is embedded rather than technical opportunity.
How We Find and Score This Setup
We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading. What the terms mean →
Frequently Asked Questions
Is SMTI a good swing trade?
SMTI scored 67 out of 98 on our falling wedge scan, with a 74% historical win probability over a 1-7 trading days hold. Moderate setup based on our systematic scoring.
What is the entry, target, and stop loss for this setup?
The setup's reference price is $31.61, with a conservative target of $33.52 and a stop loss at $28.90.
What would invalidate this falling wedge setup?
A close below the stop loss at $28.90 would invalidate the setup and suggest the pattern has failed.
How is the win probability calculated?
Win probability is a calibrated estimate of how similar historical falling wedge setups performed over the following 10 trading days, drawn from a database of 370,000+ historical pattern detections across 6,000+ NYSE and NASDAQ stocks.
Market & Sector Regime
Market
Bearish -0.24
-1.0 0 +1.0
Health Care Sector
Bullish 0.89
-1.0 0 +1.0
Other Patterns Detected Today
Bull Flag
5 days in pattern
Moderate 28.6
Overall Score
36 of 40
Exceptional
Pattern Quality
6 of 20
Weak
Setup
15 of 20
Good
R/R
10 of 18
Fair
Context
Pattern Quality Score
12 of 15
Strong
Structure
13 of 13
Exceptional
Breakout
11 of 12
Exceptional
Volume
Recent Performance
-2.2%
1W
-3.9%
2W
-10.1%
1M
-7.5%
3M
Momentum & Trend
RSI (14)
29.2
Oversold
MACD Histogram
-0.07
Bearish
Bollinger Band Position
18.5%
Lower Zone
Volatility & Risk
20-Day Volatility
0.24
Moderate
ATR %
3.2%
Medium
Beta
-0.01
Defensive
Volume Analysis
Volume Ratio
0.39x
Below Avg
20-Day Avg Vol
106K
shares / day
Current Volume
42K
shares traded
Price Levels
52W High
$35.52
Target
$33.52
Resistance
$32.28
Current
$31.61
Support
$29.23
Stop Loss
$28.90
52W Low
$16.05
Disclaimer: This analysis is algorithmically generated for educational purposes only and does not constitute financial advice. Past pattern performance does not guarantee future results. Win probabilities are based on historical data across 370,000+ observations. Always conduct your own research and consult a qualified financial advisor. AI-assisted contextual analysis by Claude (Anthropic). Indicators reflect values at time of detection.